Autologous cytokine-induced killer (CIK) immunotherapy in a case of disseminated tuberculosis

Autologous cytokine-induced killer (CIK) immunotherapy in a case of disseminated tuberculosis

Authors

  • xu ping The Fifth People’s Hospital of Suzhou , China
  • xu junchi The Fifth People’s Hospital of Suzhou , China
  • chen xinnian The Fifth People’s Hospital of Suzhou , China
  • ye zhijian The Fifth People’s Hospital of Suzhou , China
  • wu meiying The Fifth People’s Hospital of Suzhou , China

Keywords:

CIK, disseminated tuberculosi, immunotherapy

Abstract

A 23-year-old woman had dry cough, fever and chest tightness for 1 months. Through thoracic CT scan and serological examination, the patient was clinically diagnosed as disseminated tuberculosis. she was given anti-tuberculosis therapy combined with autologous cytokine-induced killer (CIK) immunotherapy. Through the close follow-ups we found that after immunotherapy Her condition would have a swift improvement and she do not appear liver damage after a large doses of antibiotic therapy. In conclusion, adjuvant autologous CIK immunotherapy is an effective approach for disseminated tuberculosis.

Downloads

Published

22-06-2015

Issue

Section

Case Reports

How to Cite

1.
ping xu, junchi xu, xinnian chen, zhijian ye, meiying wu. Autologous cytokine-induced killer (CIK) immunotherapy in a case of disseminated tuberculosis. Sarcoidosis Vasc Diffuse Lung Dis [Internet]. 2015 Jun. 22 [cited 2025 Apr. 30];32(1):83-6. Available from: https://mattioli1885journals.com/index.php/sarcoidosis/article/view/3805